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end-diastolic pressure to the left ventricular end-diastolic and mean filling pressures in patients with and without left ventricular dysfunction. Circulation 42: 65, 1970 Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol 32: 516, 1972 27. Nelson RR, Gobel FL, Jorgensen CR, Wang K, Wang Y, Taylor HL: Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 50: 1179, 1974 28. Sonnenblick EH, Ross J Jr, Braunwald E: Oxygen consumption of the heart. Newer concepts of its multifactorial determination. Am J Cardiol 22: 328, 1968 Chronic Aortic Regurgitation: The Effect of Aortic Valve Replacement on Left Ventricular Volume, Mass with the technical assistance ofL. M. Woodbury SUMMARY Serial echocardiographic left ventricular (LV) studies were performed in 19 patients before (preop) and after (postop) aortic valve replacement (AVR) for chronic aortic regurgitation (AR); the effect of AVR on LV volume, mass and function was determined from the echocardiographic data. In the 12 patients who were considered to have successful surgical results, the average LV end-diastolic dimension fell from a preop value of 6.9 ± 0.2 cm to 5.5 0.2 cm (P < 0.01) at the time of the early postop study (seven to 10 days). Muscle cross-sectional area (CSA) derived from dimension and wall thickness data was used as an index of LV muscle mass (preop CSA = 26 ± 1.3 cm2); CSA was unchanged at the early postop study, but subsequently fell to near normal within six months after AVR (20 1 cm2, P < 0.01). There was a trend toward improvement in systolic performance by the late postop studies (12+ months). In two out of three patients with postop paravalvular AR, LV dimension increased after an initial fall. Four patients without paravalvular AR failed to show a significant reduction in LV dimension in the postop studies. In this group the preop studies showed a tendency toward a large end-diastolic dimension and decreased fractional shortening, but the single preop parameter which differentiated these four from the successfully treated group was an end-diastolic radius-towall thickness (R/Th) ratio _ 4.
Thus, successful AVR for chronic AR results in the normalization of LV volume and a decrease in LV muscle mass to near normal. The R/Th ratio has important prognostic value which appears to be independent of fractional shortening in some patients with chronic AR.
OPTIMUM TIMING of valve replacement in patients with chronic left ventricular (LV) volume overload is a difficult and challenging problem. While aortic valve replacement often results in striking symptomatic and hemodynamic improvement in patients with chronic aortic regurgitation, in some instances surgical correction does little to alter the course of the disease. Furthermore, the extent to which clinical improvement is associated with regression of hypertrophy and abnormalities of ventricular function is not known. [1] [2] [3] [4] The present study was designed to examine the time course of changes in LV volume, mass and systolic performance in patients undergoing aortic valve replacement for chronic aortic regurgitation. In addition, preoperative data were examined in an effort to identify parameters which might predict which patients could expect a good result from surgery and which might not. *One episode of pulmonary edema. tPast history of bacterial endocarditis. Abbreviations: BSA = body surface area (m2); DED = left ventricular dimension at end-diastole; %AD = fractional change in dimension; PW Th = posterior wall thickness; CSA = muscle cross-sectional area; BP = blood pressure; HR heart rate; EDVI = end-diastolic volume index; SEF = systolic ejection fraction; EDP = end-diastolic pressure; RF = regurgitant fraction.
Methods
Nineteen patients who underwent aortic valve replacement for chronic aortic regurgitation between January 1975 and June 1977 were invited to participate in this study. Our protocol was approved by the Committee on Research Involving Human Beings of the Tufts-New England Medical Center Hospital; informed consent was obtained in all cases. Admission to the study required high-quality echocardiographic (echo) LV studies, while the decision to perform aortic valve replacement was based on clinical and hemodynamic criteria. Functional classification is presented in table 1. The physical findings were typical of significant aortic regurgitation, the chest x-rays showed cardiomegaly, and the ECGs revealed LV hypertrophy in all 19 patients. Two patients (3 and 17) had associated coronary surgery (single graft to the left anterior descending coronary artery), and one (patient 8) had a right ventricular transvenous pacemaker inserted postoperatively.
Seventeen of the 19 patients with aortic regurgitation underwent preoperative right and left heart catheterization using routine clinical methods. LV end-diastolic volume (EDVA) and end-systolic volume (ESVA) were determined using single plane angiography (right anterior oblique projection, area length method),5 and the systolic ejection fraction (SEF) was calculated as:
where EDVA and ESVA are end-diastolic and end-systolic volume, respectively. Total systemic blood flow was determined using the Fick principle for oxygen, and the regurgitant fraction (RF) was calculated as: RF = (SVA -SVF)/SVA (2) where SVA is the angiographic stroke volume and SVF is the Fick stroke volume. The ratio of the enddiastolic long axis to the end-diastolic short axis (ratio of the major to the minor diameter of an assumed ellipsoid) was measured from each of the angiograms to aid in the calculation of preoperative LV mass and volume from the echo diameter and wall thickness data (see below). The long axis was defined as the length from the LV apex to the junction of the aortic and mitral valves, and the short axis was derived from the area length equation. Echocardiograms were obtained with a Smith Kline ultrasonoscope and a 2.55 MHz transducer; an ECG (lead II), a carotid pulse tracing (Statham P23Db transducer), and a phonocardiogram were recorded at the time of the echo study. LV dimension at enddiastole (DED) was measured at the R wave of the ECG and the dimension at end-systole (DES) was measured as the smallest vertical dimension between the left septal echo and the posterior wall endocardium at end-systole. Posterior wall thickness (Th) was measured at end-diastole from the leading edge of the epicardial echo to the leading edge of the endocardial echo, with the gain adjustment set to minimize the width of these signals. Likewise, the septal thickness was measured from the leading edge of the right septal echoes to the leading edge of the left septal echoes. Fractional shortening (expressed as the percent change in LV dimension from end-diastole to endsystole) was calculated as:
(3) where DED is LV dimension at end-diastole, DES is LV dimension at end-systole, and %AD is fractional shortening of the LV dimension. DES and %AD were not determined when the septal motion was paradoxical or markedly hypokinetic (septal excursion 2 mm). Markedly abnormal septal motion was a uniform finding in the first postop study. The fractional increase in Th from end-diastole to end-systole was calculated as: %ATh = I(Thed -TheS)/Thed}* 100 (4) where Thed is end-diastolic wall thickness and Thes is end-systolic wall thickness. This parameter was used as an index of LV function when %AD could not be calculated due to abnormal septal motion in the early postop studies.
Echocardiographic estimates of LV volume are known to be limited by several major assumptions,6 and for this reason we did not select a single method or regression equation to follow the changes in chamber volume after surgery. LV DED was used as an index of LV EDV, and the postop change in this index was followed serially.
Echocardiographic estimation of LV muscle mass is likewise dependent on various assumptions regarding ventricular dimensions. Thus, we elected to use an index of LV myocardial mass which does not require major geometric assumptions. This index, termed the cross-sectional area (CSA) of the LV wall in a transverse plane, was calculated from the echo dimension and wall thickness at end-diastole: CSA = irl(DED/2) + Th2 -7r(DED/2)2 (5) where DED is the echo dimension at end-diastole and Th is the end-diastolic wall thickness. The index of mass was calculated serially in each patient to examine the time course of regression of chronic volume overload hypertrophy. The decision to use CSA as an index of LV muscle mass was made in part because CSA was found to be unchanged in the early postop period despite a substantial reduction in LV volume (DED). This index was developed by Sasayama et al. and was used in studies of the response of the left ventricle to chronic pressure overload. 7 LV mass was also determined by using a modification of the method of Troy et al.8 This method derives from the ellipsoid formula in which the echo dimension is assumed to be the minor diameter of the LV, and the major diameter is assumed to be twice the minor diameter (assumed ratio of the major-to-minor diameter = 2:1). A uniformly thick shell of myocardium surrounding the elliptical chamber is also assumed. Analysis of the preop LV angiograms in our patients revealed an average major-to-minor diameter ratio of 1.55:1. This ratio was used to calculate pre-op LV mass from the echo diastolic dimension and wall thickness (ellipsoid formula). Late postop (12+ months) LV mass was calculated from the echo diastolic dimension, wall thickness, and an assumed 1.8:1 ratio. Most published normal LV end-diastolic major-to-minor diameter ratios are somewhat less than 2: 1.9, 10 We selected 1.8: 1 as representative, and also examined the results of ratios ranging from 1.7:1 to 2.0: 1 (see Results section). In most instances, wall thickness was determined from the average of the septal and posterior wall thickness. However, when the right side of the septum was poorly defined, posterior wall thickness alone was used. Preoperatively, the difference between the posterior wall thickness and the interventricular septal thickness was 1 mm in all 19 patients with chronic aortic regurgitation. Because of uncertainties about ventricular geometry in the early postop period, we elected to compare only preop LV mass to late (12+ months) postop mass, and to rely on the muscle CSA to follow the time course of regression of myocardial hypertrophy. For comparison, LV mass was also calculated by the unmodified method of Troy et al. (2: 1 ratio) and by the simple cube method. 8 An index of the LV volume/mass ratio was determined from each echo study as:
where DED is LV dimension at end-diastole and Th is the LV wall thickness at end-diastole. Within a broad range of LV dimensions and mass, this index is linearly related to the volume/mass ratio and does not depend on assumptions regarding LV geometry." All 19 patients had at least one preop echocardiogram; postop studies were obtained at seven to 10 days and at 3, 6, 9, 12, 18 and 24 months after aortic valve replacement. The 19 patients were divided into three groups for data analysis. Group 1 patients (n = 12) had a satisfactory surgical result, which we defined as "6postop normalization of LV DED" (DED fell to within 2 standard deviations of the average for the normal subjects); all 12 were symptomatically improved. The effects of successful aortic valve replacement on LV dimension and mass are defined in this group. Group 2 patients (n = 3) developed postop paravalvular aortic regurgitation. Although the group 2 preop data were indistinguishable from those in group 1, these patients were examined separately. Group 3 patients (n = 4) had persistent postop LV enlargement in the absence of aortic regurgitation (DED remained > 2 standard deviations above the average for the normal group).
The normal range of the LV parameters was defined from an analysis of 30 echocardiograms from subjects (hospital staff and other volunteers) who had no clinical evidence of heart disease (control group A). A group of 12 patients with mild-to-moderate aortic insufficiency provided a second control group (control group B). All 12 had LV enlargement and normal LV fractional shortening by echo. They are asymptomatic and, based on clinical criteria, are not yet considered candidates for cardiac catheterization and/or aortic valve replacement. The data from these two control groups are shown in table 2.
The normal range for the echo parameters was defined as the average ± 2 SD; unless otherwise stated, data are presented as the mean ± SEM. Data were analyzed for statistical significance using analysis of variance on both raw data and data normalized to preoperative controls (% of preop control). Changes were considered significant if P < 0.05 by either analysis.
Results

Group I L V Dimensions
Preoperatively, all 12 The effect of aortic valve replacement on the LV study in patient 1 is shown in figure 1. The LV dimension-mass data (preop and serial postop studies) for the group 1 patients are tabulated in table 3), and the average data are presented graphically in figure 2. The average LV DED fell from a preop value of 6.9 ± 0.2 cm to 5.5 ± 0.2 cm (P < 0.01) at the early postop study (seven to 10 days). A tendency for a continued reduction in DED was present for the first nine months after surgery (at nine months, DED was significantly smaller, P < 0.05, than at 0.3 months; there was no significant change thereafter). Postoperatively, LV DED in all patients in group 1 fell within 2 standard deviations of the average for the normal group (2.7 ± 0.5 cm/m2). Abbreviations: DED left ventricular dimension at end-diastole; R/Th = radius/posterior wall thickness ratio; CSA = muscle cross-sectional area. FIGURE 1. Serial echocardiographic left ventricular (L V) studies from a representative patient (patient 1) in group 1. There was a 15 mm reduction in LV dimension at end-diastole (DED) at the time of the early postoperative study (10 days); an additional small decrease in DED was found at six months. Posterior wall thickness was increased at the time of the 10-day (postop) study, but calculated muscle cross-sectional area was unchanged; with regression ofmyocardial hypertrophy (six months), there was a reduction in posterior wall thickness. See text for details. A VR = aortic valve replacement; AI = aortic insufficiency. POST-OP (months) FIGURE 2. Serial preop and postop left ventricular (LV) data from the group I patients. As early as seven to 10 days after aortic valve replacement (0.3 months), a marked reduction in L V dimension at end-diastole (DED) was seen.
LV posterior wall thickness (PWTh) increased in the early postop study and subsequently fell to values which were nearly equal to the preop values. At the time of the early postop study, muscle cross-sectional area (CSA) was unchanged; CSA subsequentlyfell to near-normal values by six to nine months and remained essentially stable thereafter.
The radius-to-wall thickness (R/Th) ratio fell abruptly postop and subsequently increased to normal in the following months. Data are presented as average ± SEM.
L V Mass and the R/ Th Ratio
There was no significant difference between the early postop muscle CSA (27 ± 2 cm2) and the preop value (26 ± 1 cm2). The lack of a change in CSA (in the presence of a smaller DED) occurred as a result of a significant increase in posterior wall thickness (1.03 ± 0.13 to 1.21 ± 0.06 cm, P < 0.05). At three months postop, the average CSA was reduced to 23 ± 1 cm2 (P < 0.01 vs 0.3 months). CSA continued to fall at six and nine months. At nine months, the average CSA had fallen to 21 ± 1 cm2 (P < 0.01 vs three months). There were no significant changes in CSA after nine months; in most patients, between nine and 24 months, muscle CSA was within 2 standard deviations of the average for the normal subjects (8 ± 2.0 cm2/m2). This 23% decrease in muscle CSA corresponds to a 38% reduction in LV muscle mass when mass is calculated from our modification of the Troy method using the 12-18 months postop echo data (LV mass fell from 262 ± 27 to 162 + 17 g, n = 8, P < 0.05). This calculation is based on an angiographically measured preop long axis to short axis (ellipsoid) ratio of 1.55:1 and an assumed nearnormal late postop ratio of 1.8: 1. If these late postop LV mass estimates are made assuming late postop ratios ranging from 1.7:1-2.0: 1, the decrease in muscle mass ranges from 43-37%. Assuming a constant geometry (either the unmodified 2:1 method of Troy or the cube method), calculated LV mass falls by 17% at the time of the early postop study and 46% by [12] [13] [14] [15] [16] [17] [18] months.
Preoperatively, the average R/Th ratio (3.4 ± 0.09) was not significantly different from the average for the normal subjects. After aortic valve replacement (at the early postop study), the R/Th ratio fell to 2.3 ± 0.18 (P < 0.01). This index of the LV volume/mass ratio then gradually increased so as to fall within the normal range by the late postop period (table 3 and fig. 2 ).
L V Systolic Performance
The %AD was 34 ± 2% in the preop study. This is essentially the same as the %AD in the normal group (34 ± 1.4%). Markedly abnoirmal septal motion was present in all 12 early postop studies, and an example of postop paradoxical septal motion (patient 6) is shown in figure 3 . For this reason, %AD was not calculated in the early postop studies. By 12+ months, septal excursion was ' 3 mm in five of the eight patients, and in three of these five (patients 1, 2 and 5), the postop %AD was greater than the preop %AD (table 4) . Of the three patients with persistently abnormal septal motion, one had a right ventricular transvenous pacemaker (patient 8).
Abnormal septal motion in the postop period precludes calculation of the %AD, and for this reason we elected to examine the %ATh as an index of LV performance. In figure 4 the %ATh is plotted against %AD for all preop studies and from the postop studies in which septal excursion was ' 3 mm. The linear correlation coefficient between %ATh and %AD is 0.73. The average %ATh (62 A 4%) was not significantly different from the normal group (52 ± 3%). In the early postop studies, %ATh (47 + 5) was slightly less (P < 0.01) than preop; thereafter, there was a tendency to increase so that by nine months, %ATh (73 ± 7) was greater (P < 0.01) than the early postop value. While there was a tendency for %ATh to increase in the late posopstudies, these changes were not statistically significant when the late postop data were compared to the preop data (preop vs late postop). Group 2 While the three patients in group 2 had preop data which were indistinguishable from those in group 1, this group was examined separately because the !,I TIC0 tI l I-le I ;4. tI tI'l postop course was interrupted by the development of paravalvular aortic regurgitation. One patient (patient 13) out of the entire 19 had near-normal septal motion at the time of the early postop study; this patient also had persistent postop LV enlargement and was known to have a diastolic murmur. Two others (patients 14 and 15) developed a murmur and recurrent LV enlargement after an early postop decrease in DED; near-normal septal motion appeared coincident with the measured increase in DED in these two patients. Reoperation in patients 13 and 14 produced results similar to those found in the group I patients.
Group 3
In four patients, postop LV DED did not return to normal, nor did muscle CSA decrease. One of these (patient 16) died in refractory congestive heart failure nine months after surgery; patient 17 is asymptomatic (this patient had associated coronary bypass surgery and it is possible that coronary disease con-tributed to the failure of his LV cavity size to normalize); patients 18 and 19 complain of weakness and fatigue. Preoperative data from all 19 patients were examined in a search for clues which might predict the poor (group 3) response to surgery.
Predictors of the Response to Surgery
Preoperative dimeneon-mass data for all 19 patients and for the 30 normal subjects are shown in figure 5 . While two of the patients in group 3 had a larger DED than those in group 1, there was considerable overlap between these two groups. Likewise, groups 1 and 3 did not differ in terms of wall thickness or muscle CSA. However, the R/Th ratio was _ 4.0 in all group 3 patients, while this ratio was 3.9 or less in all group 1 patients.
Preoperative angiographic ejection fraction (SEF) and echocardiographic %zXD are shown in figure 6 . The SEF in all group 1 patients was > 50%, while two of the four patients in group 3 also had a SEF of and 3) with chronic aortic regurgitation. Datafrom 30 normal subjects (N) are shown for comparison. There was considerable overlap in LV dimension at end-diastole (DED) between groups I and 3. Likewise, LV posterior wall thickness (PWTh) and muscle cross-sectional area (CSA) did not differ between groups. In contrast, the RI Th ratio (an index of the L V volume/mass ratio) was 3.9 in all group I patients and 2 4.0 in all group 3 patients. BSA = body surface area. > 50%. Preoperative %AD was within the normal range in two of the four patients in group 3. Analysis of other preop catheterization data (table 1) did not uncover significant differences between groups 1 and 3.
In addition to preop hemodynamic (catheteriza-14*. . Preoperative left ventricular systolic performance and the radius-to-wall thickness ratio (R/Th) from 19 patients with chronic aortic regurgitation. The angiographic systolic ejection fraction (SEF) was greater than 50% in all of the group I patients and in two ofthefour group 3 patients; fractional shortening (%AD) by echo was less than 28 in two of the group 1 patients and was greater than 30 in the two group 3 patients. Fractional shortening (%AD) is plotted against the RI Th ratio in the panel on the right. While all group 3 patients had a preop R/ Th > 4 and all group I patients had an RITh ! 3.9, fractional shortening was normal in two of the four group 3 patients and abnormal in two of the group 1 patients. .: m the R/Th ratio. Figure 6 shows that this ratio appears to be independent of fractional shortening in some patients. Discussion
The regression of myocardial hypertrophy has been studied extensively in animals, but there is very little information on this subject in man. The major objective of this study was to determine if advanced volume overload myocardial hypertrophy in man (secondary to chronic aortic regurgitation) is reversible following aortic valve replacement, and if so, to define the extent and time course of such regression of hypertrophy and to determine the associated functional changes. During the course of the study, it became apparent that regression of hypertrophy (and a decrease in chamber dimension) was not uniformly found after corrective surgery. Accordingly, preop data were examined in a search for parameters which might predict the outcome of aortic valve replacement in patients with chronic aortic regurgitation.
In the patients who did well (group 1) we found an impressive early postop decrease in LV DED, with a smaller additional reduction by the time of the late postop studies. Application of the commonly-used LV volume regression equations yield a postoperative decrease in LV volume ranging from 50-60%; 75% of this change occurred within seven to 10 days of aortic valve replacement. Muscle CSA did not change in the early postop studies (seven to 10 days), but did show a significant decrease (12%) by three months postop and a further (15%) decrease by six months. This 25-30% decrease in CSA corresponds to a 40% reduction in LV mass or an absolute reduction of 100 grams of LV muscle (modified Troy method). While the average late postop (12+ months) CSA for the group 1 patients was near-normal, some individual variability was found. For example, late postop muscle CSA was clearly normal in patient 1, and remained somewhat increased in patient 2 (8 and 13 cm2/m', respectively).
These changes in LV volume and mass after correction of chronic aortic regurgitation are similar to those reported by others. Using echocardiography, Burggraf and Craige found a significant decrease in LV DED from 68 ± 7 to 52 t 3 mm within two months of aortic valve replacement for chronic aortic regurgitation. ' despite an impressive decrease in hypertrophy, LV mass did not return to within 2 standard deviations of normal. Similarly, while regression of hypertrophy occurred in the dog studies of Papadimitriou et al., LV mass did not return to normal. However, the myocardial ultrastructure (which was abnormal at 78 days postop) was hardly distinguishable from normal at 178 days after surgery.
Fractional shortening in the late postop studies (12+ months) was greater than preop in three out of five patients, and as seen in table 4, there was also a tendency for the systolic change in wall thickness to increase in the late postop studies. Schuler also found a tendency for LV systolic performance to increase late following correction of chronic aortic regurgitation,'3 but others have found little change in angiographic ejection fraction or echocardiographic fractional shortening.'4-"1 Our decision to use %ATh as an index of LV performance was based on the uniform presence of abnormal septal motion in the early postop studies which precluded calculation of fractional shortening. While there was a good correlation (r= 0.73) between %zATh and %AD in our patients ( fig. 4 ) and in the animal studies of Sasayama et al.,'7 the wide range of normal (mean ± 2 SD = 52 ± 30%) limits its applicability in man, except perhaps in serial studies of the same patient.
The afterload dependency of %zATh (and the other ejection phase indices of contractility) should also be considered when these indices are used in patients with valvular heart disease.', 19 Marked reductions in afterload (and preload) occur in the early postop period after correction of aortic regurgitation, and while this might be expected to cause an increase in %oATh, this index actually was found to be decreased at the time of the sevento 10-day postop studies. This decrease in %ATh probably reflects a depressed LV contractile state in the early postop period. The return of %zAD and %ATh to preop levels (and the tendency to exceed preop levels) likely reflects a more normal or appropriate relation between afterload and contractile state at the time of the late postop studies.
We conclude, therefore, that 1) LV volume returns to near normal within seven to 10 days after successful aortic valve replacement; 2) significant regression of volume overload hypertrophy occurs during the first six to nine months after surgery; and 3) late postop systolic performance may be greater than preop in some patients.
Thus, while it appears that important reductions in LV volume and mass may occur following correction of chronic LV volume overload, such changes are not uniformly found. In our group 3 patients and in four of the five patients reported by Gault et al.,20 there was little change in LV mass following aortic valve replacement. Markedly increased LV DED and decreased fractional shorteningappear to be poor prognostic signs in some patients, but the single preop echo parameter which separated group 1 from group 3 was the R/Th ratio. This ratio, an index of the LV volume/mass ratio, reflects the degree to which the LV muscle mass is appropriate for a given chamber volume.
Using angiographic techniques, Levine et al. calculated the ratio of cavity diameter (C) to the LV wall thickness (W) and used the C/W ratio as an index of the volume/mass ratio;2' they observed that C/W was low in patients with LV outflow obstruction (pressure overload) and that C/W did not differ from normal in patients with aortic or mitral regurgitation. The terms "concentric" and "eccentric" hypertrophy were later introduced by Grant et al. to describe the relation between ventricular mass and volume.22 A ventricle with eccentric hypertrophy (as occurs in chronic compensated aortic regurgitation) was considered by Grant to be a "magnified" normal ventricle, and thus, the myocardial mass relative to the diastolic chamber volume was normal. In contrast, the ventricle with concentric hypertrophy (as occurs in aortic stenosis) develops an increased wall thickness relative to chamber size and is characterized by a low volume/mass ratio (V/M) as well as by a low chamber R/Th. Grossman et al. have expanded these concepts and have defined further the patterns of concentric and eccentric hypertrophy by calculating wall stress and the Th/R ratio (the inverse of R/Th) in patients with pressure overload and in patients with volume , KK 4-
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R/Th = 1/0.0027 P overload.23 These investigators present an appealing hypothesis which describes the pattern of hypertrophy relative to the stimulus for hypertrophy. Again, the relation between muscle mass and ventricular volume expressed as the ratio of wall thickness to internal radius was found to remain within the normal range in patients with chronic LV volume overload.
In a study of 36 patients with cardiomyopathy and depressed SEF, Feild et al. made the observation that the degree of relative hypertrophy, expressed as the mass/volume ratio, influenced survival.24 Furthermore, their data suggest that the influence of this ratio on survival is "at least in part independent of the ejection fraction."
In the present study, the R/Th ratio was used as an index of the V/M ratio. This index of V/M is appealing not only because it can be easily measured directly from clinical echocardiograms, but also because the R/Th is linearly related to the V/M ratio over a broad range of ventricular dimensions. While the average preop R/Th ratio in our group 1 patients was not significantly different from the values obtained in our normal subjects, the preop values for R/Th in the group 3 patients not only exceeded our normal range, but was greater than the highest R/Th in group 1. I  I  I  I  I  I  I   I   N hypertrophy relative to LV volume. Among the parameters examined preoperatively, only the R/Th ratio successfully distinguished group 3 from group 2 patients. Certain qualifications are necessary before the R/Th can be used to reflect prognosis in patients with chronic aortic regurgitation. First, acute aortic regurgitation must be excluded, since an acute LV volume overload would result in an abrupt increase in R/Th. Secondly, and importantly, the R/Th must be "normalized" for LV systolic pressure. The rationale for pressure normalization of R/Th rests in the relationship between wall stress and pressure, radius and wall thickness. Since the R/Th ratio at end-diastole is nearly equal to the R/Th at the time of peak systolic stress,22 the product of peak systolic pressure and the R/Th ratio provides an index of peak systolic stress. In our group 3 patients, this index was 25% greater than that found in our group 1 patients. Peak systolic stress is known to be near normal in patients with chronic compensated heart disease and increased in some decompensated hearts. 23 25, 26 It thus appears that the prognostic value of the R/Th ratio (_ 4) is a reflection of increased peak systolic stress in our group 3 patients.
Ford" has discussed the physiologic importance of the relation between LV systolic pressure (P) and enddiastolic R/Th and has expressed this relation (for normal or compensated hearts) as: R/Th = 1/0.0027P. The curvilinear line in figure 7 is derived from Ford's equation. The range of normal in our laboratory, shown by the broken line in figure 7 (control group A, table 4), is consonant with Ford's data. The patients with mild aortic regurgitation (control group B, table 4) lie within or near the normal range. Preoperative data from our group 1 patients lie above and to the right of normal, and data from the patients in group 3 lie even further up and to the right. The deviation of the group 3 patients from the normal R/Th relation reflects a failure of hypertrophy to match the load imposed on the ventricle. Based on this analysis and on the observations of Feild et al., 24 we conclude that LV hypertrophy is not only a critical compensatory mechanism, but that insufficient muscle mass, relative to chamber size, implies a poor prognosis.
